The present invention relates to a composition and method comprising
purified HA, a second anti-neoplastic agent and a pharmaceutically
acceptable carrier, wherein the purified HA and the second
anti-neoplastic agent are administered to a mammal having cancer in an
amount effective to treat the cancer.